Modeling of in hospital mortality determinants in myocardial infarction patients, with and without type 2 diabetes, undergoing pharmaco-invasive strategy: The first national report using two approaches in Iran

Diabetes Research and Clinical Practice

Volumn 108, Issue 2, 2015, Pages 216-222

  Ahmadi, Ali ^a   Soori, Hamid ^b   Sajjadi, Homeira ^c  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Coronary artery bypass grafting; Mortality; Myocardial infarction; Percutaneous coronary intervention; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EDUCATION; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; AGED; COMPARATIVE STUDY; COMPLICATION; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 84927909986     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.02.018     Document Type: Article

References (32)

1. Onen C.L. Epidemiology of ischaemic heart disease in sub-Saharan Africa. Cardiovasc J Afr 2013, 24:34-42.
2. Ahmadi A., Soori H., Mobasheri M., Etemad K., Khaledifar A. Heart failure, the outcomes, predictive and related factors in Iran. J Mazandaran Univ Med Sci 2014, 24:180-188.
3. Ahmadi A., Soori H., Mehrabi Y., Etemad K., Samavat T., Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: a study using national registry data in 2012. East Mediterr Health J 2015, 21:5-12.
4. Bulugahapitiya U., Siyambalapitiya S., Sithole J., Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009, 26:142-148.
5. Lee W.L., Cheung A.M., Cape D., Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000, 23:962-968.
6. Hirakawa Y., Masuda Y., Kuzuya M., Iguchi A., Kimata T., Uemura K. Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II. Diabetes Res Clin Pract 2007, 75:59-64.
7. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103:137-149.
8. Ahmadi A., Hasanzadeh J. Metabolic control and care assessment in patients with type 2 diabetes in Chaharmahal & Bakhtiyari Province 2008. Iran J Endocrinol Metab 2009, 11:33-39.
9. Ahmadi A., Mobasheri M., Hashemi-Nazari S.S., Baradaran A., Choobini Z.M. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: a cohort study. J Res Med Sci 2014, 19:840-845.
10. Esteghamati A., Etemad K., Koohpayehzadeh J., Abbasi M., Meysamie A., Noshad S., et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract 2014, 103:319-327.
11. Boya F., Bandarian F., Larijani B. Potential risk factors diabetes neuropathy. BMC Neurol 2005, 5:1-5.
12. Ahmadi A., Hasanzadeh J. To determine the relative factors on hypertension in Kohrang, Chaharmahal & Bakhtiari province. Iran J Epidemiol 2008, 4:19-25.
13. Hammoud T., Tanguay J.F., Bourassa M.G. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 2000, 36:355-365.
14. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011, 2011:e574-e651.
15. Steg P.G., James S.K., Atar D., Badano L.P., Blomstrom-Lundqvist C., Borger M.A., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
16. Nasri H., Behradmanesh S., Ahmadi A., Baradaran A., Nasri P., Rafieian-Kopaei M. Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev 2014, 3:14-18.
17. Mendis Shanthi, Thygesen K., Kuulasmaa Kari World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011, 40:139-146.
18. Sicree R., Shaw J., Zimmet P. Diabetes and impaired glucose tolerance. Diabetes atlas 2006, 15-109. International Diabetes Federation, Brussels. 3rd ed. D. Gan (Ed.).
19. Rasoul S., Ottervanger J.P., Timmer J.R., et al. Impact of diabetes on outcome in patients with non-ST-elevation myocardial infarction. Eur J Intern Med 2011, 22:89-92.
20. Ekezue B.F., Laditka S.B., Laditka J.N., et al. Diabetes complications and adverse health outcomes after coronary revascularization. Diabetes Res Clin Pract 2014, 103:530-537.
21. Gnavi R., Canova C., Picariello R., Tessari R., Giorda C., Simonato L., et al. Mortality, incidence of cardiovascular diseases, and educational level among the diabetes and non-diabetes populations in two large Italian cities. Diabetes Res Clin Pract 2011, 92:205-212.
22. Juutilainen A., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Type 2 diabetes as a coronary heart disease equivalent: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005, 28:2901-2907.
23. Zhang F., Yang Y., Hu D., Lei H., Wang Y. Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetes patients with multi-vessel coronary disease: a meta-analysis. Diabetes Res Clin Pract 2012, 97:178-184.
24. Lee M.S., Yang T., Dhoot J., Iqbal Z., Liao H. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol 2010, 105:1540-1544.
25. Kanaya A.M., Grady D., Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002, 162:1737-1745.
26. Zuanetti G., Latini R., Maggioni A.P., Santoro L., Franzosi M.G. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993, 22:1788-1794.
27. Cho E., Rimm E.B., Stampfer M.J., Willett W.C., Hu F.B. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002, 40:954-960.
28. Pyorala K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., Thorgiersoon G. Cholesterol lowering with simvastatin improves prognosis of diabetes with coronary heart disease. Diabetes Care 1997, 20:614-620.
29. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353.
30. Zaliunas R., Babarsicilenc M.R., Luksiene D., Slapinkiene B., Milvidatite T., Veneloviene J. Ischemic heart disease: mortality risk in patient with diabetes mellitus. Medicina 2003, 39:640-650.
31. Merry A.H., Boer J.M., Schouten L.J., Feskens E.J., Verschuren W.M., Gorgels A.P., et al. Smoking, alcohol consumption, physical activity, and family history and the risks of acute myocardial infarction and unstable angina pectoris: a prospective cohort study. BMC Cardiovasc Disord 2011, 11:13.
32. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001, 161:1717-1723.